Drug Prices in 2026: How New Healthcare Policies Could Change Pharmaceutical Access
by Drug pricing in the U.S. is entering a new phase in 2026. The biggest change is no longer only about whether medicines are expensive. It …
Global Vaccine Trends in 2026: COVID-19, Mpox, Measles and the Next Public Health Challenge
The global vaccine industry is entering a different phase in 2026. COVID-19 vaccination is moving toward more targeted seasonal protection. Mpox has become a long-term …
Germany Radiopharmaceuticals Market Size, Share and Growth Forecast 2035
Germany is becoming an increasingly important European hub for radiopharmaceuticals as cancer care moves toward molecular imaging, targeted radionuclide therapy, and theranostics. Public industry estimates …
Brazil Pharmaceutical Contract Manufacturing Market Size, Share and Growth Forecast 2035
The Brazil pharmaceutical contract manufacturing sector is gaining strategic importance as pharmaceutical companies seek scalable production, regulatory-compliant manufacturing, cost efficiency and access to established local …
In Vivo CAR-T Therapy in 2026: Are We About to Change How Cell Therapy Is Made?
What if CAR-T therapy no longer required collecting a patient’s immune cells, sending them to a specialized manufacturing facility, genetically engineering them, expanding them, testing …
Gene Therapy in 2026: FDA Approvals, Clinical Breakthroughs and the Biggest Challenges
Gene therapy in 2026 is entering a more commercially important phase. The industry is no longer asking whether genetic diseases can be treated by modifying …
Why Did BioNTech Halt Its Colorectal Cancer Vaccine Trial? What It Means for mRNA Cancer Vaccines
BioNTech’s decision to terminate its Phase 2 colorectal cancer vaccine trial is an important warning for the mRNA oncology industry: promising technology alone does not …
GLP-1 2.0: What Comes After Ozempic and Mounjaro?
The obesity drug market is entering a new competitive phase. The first question was whether GLP-1 therapies could transform obesity treatment. They already have. Sample …
Cancer Vaccines in 2026: Is mRNA Ready to Transform Cancer Treatment?
mRNA has already changed vaccine development. The bigger question now is: Can mRNA become a scalable platform for personalized cancer treatment? The answer in 2026 …
Obesity Drug Market 2026 – 2030: Why the Next Battle Goes Beyond GLP-1
The next battle in obesity treatment is no longer simply GLP-1 vs. GLP-1. Between 2026 and 2030, competition is likely to be defined by a …